The Strait of Hormuz blockade and escalating West Asia tensions have driven up medical device input costs by nearly 50 per cent for critical plastics.
The Strait of Hormuz blockade and escalating West Asia tensions have driven up medical device input costs by nearly 50 per cent for critical plastics. Rising shipping costs, broken logistics routes and crude-linked API price pressures are affecting production and export reliability. Southeast Asia, East Africa, and Latin America are places where Indian preventive healthcare products have strong scientific backing and are competitively priced. The West Asia crisis is putting Indian pharmaceutical and preventive healthcare exports to the test, especially for nutraceutical and functional health exporters. For confidential support call the Samaritans in the UK on 08457 90 90 90, visit a local Samaritans branch or click here for details.
Source Coverage Analysis
View all 1 sources
| Firstpost | 1 article | Unknown |
Related Articles
West Asia crisis hits Indian pharma exports; industry calls for âHealth Security Corridorâ to secure supply chains
FirstpostThe Strait of Hormuz blockade and escalating West Asia tensions have driven up medical device input costs by nearly 50 per cent for critical plastics. Rising shipping costs, broken logistics routes an...